In a world shaped by biotechnology, why are so few college students exposed to its possibilities early on in their education?

Some three months after the company first disclosed partnership interest, CRISPR Therapeutics board member and SR One CEO Simeon George, M.D., says it’s “still early days” for sealing new deals.

The industry delivered RNA vaccines to save countless lives during the pandemic and has created impressive early ... OF BIOTECH is an essential virtual summit (spanning two half days) featuring ...

Biotech investments are largely hit or miss ... However, I must emphasize that it is early days yet. NX-5948 is still in its Phase 1 trial, which realistically puts FDA approval years into the ...

LONDON, May 14 (Reuters) - Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the ...